These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28273641)

  • 1. Betulinic acid attenuates renal fibrosis in rat chronic kidney disease model.
    Sharma A; Thakur R; Lingaraju MC; Kumar D; Mathesh K; Telang AG; Singh TU; Kumar D
    Biomed Pharmacother; 2017 May; 89():796-804. PubMed ID: 28273641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorative effect of ursolic acid on renal fibrosis in adenine-induced chronic kidney disease in rats.
    Thakur R; Sharma A; Lingaraju MC; Begum J; Kumar D; Mathesh K; Kumar P; Singh TU; Kumar D
    Biomed Pharmacother; 2018 May; 101():972-980. PubMed ID: 29635907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betulinic acid ameliorates experimental diabetic-induced renal inflammation and fibrosis via inhibiting the activation of NF-κB signaling pathway.
    Wang S; Yang Z; Xiong F; Chen C; Chao X; Huang J; Huang H
    Mol Cell Endocrinol; 2016 Oct; 434():135-43. PubMed ID: 27364889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jian-Pi-Yi-Shen formula ameliorates renal fibrosis-induced anemia in rats with chronic kidney disease.
    Huang H; Huang S; Li C; Zhang C; Wang R; Wei L; Wu J; Mo P; Li Z; Li S; Chen J
    J Ethnopharmacol; 2024 Dec; 335():118607. PubMed ID: 39069029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lindera aggregata intervents adenine-induced chronic kidney disease by mediating metabolism and TGF-β/Smad signaling pathway.
    Cai H; Wang J; Luo Y; Wang F; He G; Zhou G; Peng X
    Biomed Pharmacother; 2021 Feb; 134():111098. PubMed ID: 33341058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targets for treating fibrotic kidney diseases.
    Lee SY; Kim SI; Choi ME
    Transl Res; 2015 Apr; 165(4):512-30. PubMed ID: 25176603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
    Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
    Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephroprotective effect of pioglitazone in a Wistar rat model of adenine‑induced chronic kidney disease.
    Pérez-Villalobos MC; Barba-González A; García-Carrillo N; Muñoz-Ortega MH; Sánchez-Alemán E; Ávila-Blanco ME; Morones-Gamboa JC; Ventura-Juárez J; Martínez-Hernández SL
    Exp Ther Med; 2024 Oct; 28(4):392. PubMed ID: 39161617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative/Nitrative Stress and Inflammation Drive Progression of Doxorubicin-Induced Renal Fibrosis in Rats as Revealed by Comparing a Normal and a Fibrosis-Resistant Rat Strain.
    Szalay CI; Erdélyi K; Kökény G; Lajtár E; Godó M; Révész C; Kaucsár T; Kiss N; Sárközy M; Csont T; Krenács T; Szénási G; Pacher P; Hamar P
    PLoS One; 2015; 10(6):e0127090. PubMed ID: 26086199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reno-protection of Urine-derived Stem Cells in A Chronic Kidney Disease Rat Model Induced by Renal Ischemia and Nephrotoxicity.
    Zhang C; George SK; Wu R; Thakker PU; Abolbashari M; Kim TH; Ko IK; Zhang Y; Sun Y; Jackson J; Lee SJ; Yoo JJ; Atala A
    Int J Biol Sci; 2020; 16(3):435-446. PubMed ID: 32015680
    [No Abstract]   [Full Text] [Related]  

  • 11. Attenuation of mTOR Signaling Is the Major Response Element in the Rescue Pathway of Chronic Kidney Disease in Rats.
    Wang J; Chai L; Lu Y; Lu H; Liu Y; Zhang Y
    Neuroimmunomodulation; 2020; 27(1):9-18. PubMed ID: 32526762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupi Yishen formula may prevent kidney fibrosis by modulating fatty acid metabolism in renal tubules.
    Liu B; Jie X; Deng J; Zhang S; Lu F; Liu X; Zhang D
    Phytomedicine; 2023 Jun; 114():154767. PubMed ID: 37001297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betulinic acid, isolated from the leaves of Syzygium cumini (L.) Skeels, ameliorates the proteinuria in experimental membranous nephropathy through regulating Nrf2/NF-κB pathways.
    Sutariya B; Taneja N; Saraf M
    Chem Biol Interact; 2017 Aug; 274():124-137. PubMed ID: 28711658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β/Smad3 signalling pathway in vivo and in vitro.
    Wu X; Guan Y; Yan J; Liu M; Yin Y; Duan J; Wei G; Hu T; Weng Y; Xi M; Wen A
    J Pharm Pharmacol; 2015 Aug; 67(8):1054-65. PubMed ID: 25864844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.
    Ni H; Chen J; Pan M; Zhang M; Zhang J; Chen P; Liu B
    J Mol Histol; 2013 Dec; 44(6):693-703. PubMed ID: 23907620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yishen-Qingli-Huoxue formula attenuates renal fibrosis by inhibiting indoxyl sulfate via AhR/snai1 signaling.
    Chen C; Sun S; Zhao J; Wu Q; He W; Sun W
    Phytomedicine; 2023 Jan; 108():154546. PubMed ID: 36410103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betulinic Acid Improves Cardiac-Renal Dysfunction Caused by Hypertrophy through Calcineurin-NFATc3 Signaling.
    Hong MH; Na SW; Jang YJ; Yoon JJ; Lee YJ; Lee HS; Kim HY; Kang DG
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalpol Attenuates Oxidative Stress and Inflammation via Mechanisms Involving Sirtuin-1 Activation and NF-κB Inhibition in Experimentally-Induced Chronic Kidney Disease.
    Zaaba NE; Al-Salam S; Beegam S; Elzaki O; Yasin J; Nemmar A
    Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sildenafil on rats with adenine-Induced chronic kidney disease.
    Ali BH; Al Za'abi M; Adham SA; Al Suleimani Y; Karaca T; Manoj P; Al Kalbani J; Yasin J; Nemmar A
    Biomed Pharmacother; 2018 Dec; 108():391-402. PubMed ID: 30236848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleoylethanolamide attenuates acute-to-chronic kidney injury: in vivo and in vitro evidence of PPAR-α involvement.
    Comella F; Lama A; Pirozzi C; Annunziata C; Piegari G; Sodano F; Melini S; Paciello O; Lago Paz F; Meli R; Mattace Raso G
    Biomed Pharmacother; 2024 Feb; 171():116094. PubMed ID: 38183745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.